Biology Reference
In-Depth Information
Muro-Cacho CA, Pantaleo G, Fauci A. 1995. Analysis of apoptosis in lymph nodes of HIV-
infected persons. Intensity of apoptosis correlates with the general state of activation of the
lymphoid tissue and not with the stage of disease or viral burden. J Immunol 154: 5555±5566.
Naora H, Gougeon M-L. 1999a. Enhanced survival and potent expansion of the natural killer cell
population of HIV-infected individuals by exogenous IL-15. Immunol Lett 68: 359±367.
Naora H, Gougeon M-L. 1999b. Activation, survival and apoptosis of CD45R0
and CD45R0
ÿ
T
cells of HIV-infected individuals: e¨ects of IL-15 and comparison with IL-2. Immunology 97:
181±187.
Naora H, Gougeon M-L. 1999c. Interleukin-15 is a potent survival factor in the prevention of
spontaneous but not CD95-induced apoptosis in CD4 and CD8 T lymphocytes of HIV-infected
individuals. Correlation with its ability to increase Bcl-2 expression. Cell Death Di¨ 6: 1002±
1011.
Ohnimus H, Heinkelein M, Jassoy C. 1997. Apoptotic cell death upon contact of CD4
T lym-
phocytes with HIV glycoprotein-expressing cells is mediated by caspases but bypasses CD95
(Fas/Apo-1) and TNF receptor 1. J Immunol 159: 5246±5252.
Ortiz GM, Nixon DF, Trkola A, Binley J, Jin X, Bonhoe¨er S, Kuebler PJ, Donahoe SM,
Demoitie DA, Kakimoto WM, et al. 1999. HIV-1-speci®c immune responses in subjects who
temporarily contain virus replication after discontinuation of highly active antiretroviral ther-
apy. J Clin Invest 104: R13±R18.
Pakker, et al. 1998. Biphasic kinetics of peripheral blood T cells after triple combination therapy in
HIV-1 infection: a composite redistribution and proliferation. Nat Med 4: 208±214.
Piazza C, Gilardini Montani MS, Moretti S, Cundari E, Piccolella E. 1997. CD4
T cells kill CD8
T cells via Fas/Fas ligand-mediated apoptosis. J Immunol 158: 1503±1506.
Pitcher CJ, Quittner C, Peterson DM, Connors M, Koup RA, Maino VC, Picker LJ. 1999. HIV-1-
speci®c CD4
T cells are detectable in most individuals with active HIV-1 infection, but decline
with prolonged viral suppression. Nat Med 5: 518±525.
Rosok JE, Stent G, Bjerknes R, Voltersvik P, Olofsson J, Asjo B. 1998. Correlates of apoptosis of
CD4
and CD8
T cells in tonsillar tissue in HIV type 1 infection. AIDS Res Hum Retroviruses
14: 1635±1643.
Sachsenberg N, et al. 1998. Turnover of CD4 and CD8 T lymphocytes in HIV-1 infection as mea-
sured by Ki67 antigen. J Exp Med 187: 1295±1303.
Schmitz JE, Kuroda MJ, Santra S, Sasseville VG, Simon MA, Lifton MA, Racz P, Tenner-Racz K,
Dalesandro M, Scallon BJ, et al. 1999. Control of viremia in simian immunode®ciency virus
infection by CD8
lymphocytes. Science 283: 857±860.
Sloand EM, Kumar PN, Kim S, Chaudhuri A, Weichold FF, Young NS. 1999. HIV-1 protease
inhibitor modulates activation of peripheral blood CD4
T cells and decreases their suscepti-
bility to apoptosis in vitro and in vivo. Blood 94: 1021±1027.
Sloand EM, Young NS, Kumar P, Weichold FF, Sato T, Maciejewski JP. 1997. Role of Fas ligand
and receptor in the mechanism of T-cell depletion in AIDS: e¨ect on CD4
lymphocyte deple-
tion and HIV replication. Blood 89: 135.
Stewart SA, Poon B, Jowett JBM, Chen ISY. 1997. HIV-1 Vpr induces apoptosis following cell cyle
arrest. J Virol 71: 5579±5592.
Terai C, Kornbluth RS, Pauza CD, Richman DD, Carson DA. 1991. Apoptosis as a mechanism
of cell death in cultured T lymphoblasts acutely infected with HIV-1. J Clin Invest 87: 1710±
1715.
Westendorp MO, Frank R, Oschsenbauer C, Stricker K, Dhein J, Walczak H, Debatin K-M,
Krammer PH. 1995. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and
gp120. Nature 375: 497±501.
Yao X, et al. 1998. Vpr stimulates viral expression and induces cell killing in HIV-1 infected divid-
ing Jurkat T cells. J Virol 72: 4686±4693.
